Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4271 |  HYPD Hyperion DeFi, Inc. - Common Stock | 3.30 USD | +3.77% | +19.13% | +28.91% | -46.08% | 51.28 M USD | ||
| 4273 |  ATYR aTyr Pharma, Inc. - Common Stock | 0.50 USD | 0.00% | -10.71% | +4.17% | -48.45% | 49.04 M USD | ||
| 4277 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 2.87 USD | 0.00% | -5.90% | -51.27% | -69.82% | 48.59 M USD | ||
| 4293 |  MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.22 USD | -0.81% | -0.81% | +0.83% | -15.28% | 46.09 M USD | ||
| 4294 |  MREO Mereo BioPharma Group plc - American Depositary Shares | 0.29 USD | 0.00% | -6.45% | +3.57% | -83.33% | 46.31 M USD | ||
| 4295 |  GRCE Grace Therapeutics, Inc. - Common Stock | 2.13 USD | -3.18% | -4.05% | -7.39% | -46.48% | 44.81 M USD | ||
| 4297 |  CNTX Context Therapeutics Inc. - Common Stock | 0.48 USD | -4.00% | -7.69% | -21.31% | -46.07% | 44.10 M USD | ||
| 4300 |  MCRB Seres Therapeutics, Inc. - Common Stock | 4.54 USD | -0.44% | -0.66% | -8.84% | -44.84% | 45.13 M USD | ||
| 4302 |  VERU Veru Inc. - Common Stock | 2.51 USD | -4.92% | -5.99% | +7.26% | +5.02% | 42.80 M USD | ||
| 4310 |  KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.85 USD | -5.61% | -5.61% | -75.17% | -80.81% | 41.96 M USD | ||
| 4315 |  TVGN Tevogen Bio Holdings Inc. - Common Stock | 6.44 USD | -4.59% | -2.28% | +41.23% | +592.47% | 41.93 M USD | ||
| 4327 |  EDSA Edesa Biotech, Inc. - Common Shares | 4.21 USD | -4.97% | -29.12% | -21.31% | +71.84% | 40.59 M USD | ||
| 4332 |  HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.85 USD | -2.30% | +112.50% | +102.38% | -36.09% | 41.31 M USD | ||
| 4339 |  ALGS Aligos Therapeutics, Inc. - Common stock | 6.47 USD | -3.00% | -2.12% | +59.36% | -33.91% | 40.35 M USD | ||
| 4363 |  CRVO CervoMed Inc. - Common Stock | 2.61 USD | -0.38% | -2.25% | -4.40% | -71.69% | 39.46 M USD | ||
| 4406 |  BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 USD | -11.30% | +4.64% | 0.00% | -39.83% | 31.41 M USD | ||
| 4409 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.09 USD | -2.68% | +2.83% | +25.29% | +4.81% | 34.27 M USD | ||
| 4417 |  QNCX Quince Therapeutics, Inc. - Common Stock | 33.00 USD | -2.74% | -5.53% | +86.97% | +1924.54% | 33.56 M USD | ||
| 4425 |  LITS Lite Strategy, Inc. - Common Stock | 1.00 USD | +1.01% | +11.11% | +2.04% | -66.44% | 34.03 M USD | ||
| 4436 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.72 USD | -2.70% | -4.00% | -4.00% | -20.88% | 31.32 M USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |